Bioabsorbable Stents Market Report 2026

Bioabsorbable Stents Market Overview

• Bioabsorbable Stents market size has reached to $0.41 billion in 2025 • Expected to grow to $0.65 billion in 2030 at a compound annual growth rate (CAGR) of 9.5% • Growth Driver: Heart Failure Epidemic Drives Surge In Bioabsorbable Stents Market • Market Trend: MicroPort Scientific Corporation Launches World's First Next-Generation Fully Bioresorbable Cardiac Stent, Firesorb, with Market Approval in China • North America was the largest region in 2025 and Western Europe is the fastest growing region.

What Is Covered Under Bioabsorbable Stents Market?

Bioabsorbable stents are tubes inserted into blood vessels to unblock passageways and dissolve in the body after a period of time. The main products of bioabsorbable stents are polymer-based bioabsorbable stents and metal-based bioabsorbable stents. Bioresorbable stents (BRS) or vascular scaffolds are coronary stents that can fully dissolve in the body. It is also segmented by absorption rate into slow-absorption stents and fast-absorption that are used in various applications such as coronary artery diseases, and peripheral artery diseases.

What Is The Bioabsorbable Stents Market Growth Forecast?

The bioabsorbable stents market size is expected to see strong growth in the next few years. It will grow to $0.65 billion in 2030 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to increasing demand for temporary vascular support solutions, rising focus on long-term patient outcomes, expansion of peripheral artery disease treatments, growing investments in biodegradable implant research, increasing regulatory approvals for novel stent materials. Major trends in the forecast period include increasing development of next-generation bioabsorbable materials, rising adoption of polymer-based bioabsorbable stents, growing focus on reduced long-term complications, expansion of clinical trials for peripheral applications, enhanced emphasis on biocompatibility and safety.

What Are The Drivers Of The Bioabsorbable Stents Market?

The increasing rate of heart failure is expected to drive the growth of bioabsorbable stents market. Heart failure is characterized by the heart muscle's reduced ability to efficiently pump blood, resulting in the accumulation of excess fluid within the body. Bioabsorbable stents can be employed in the management of heart failure to enhance cardiac performance and mitigate its symptoms. For instance, the Heart and Stroke Foundation of Canada, a Canada-based source of information about stroke, heart disease, surgeries and treatments, reports a current count of 750,000 individuals diagnosed with heart failure, with an annual increase of 100,000 new cases of this incurable condition. Projections indicate that by 2030, healthcare expenditures related to heart failure in Canada are anticipated to reach $2.8 billion annually. Therefore, the increasing rate of heart failure will be propelling the growth of bioabsorbable stents industry going forward. The growing geriatric population is expected to propel the growth of the bioabsorbable stents market going forward. The geriatric population refers to people who are generally 65 years of age or older and classified as older adults. Geriatric population is rising due to increasing life expectancy driven by advances in healthcare, which enable people to live longer and reach older age groups. Bioabsorbable stents are beneficial for the geriatric population as they gradually dissolve after restoring blood flow, reducing long-term complications and eliminating the need for permanent implants in older patients with higher susceptibility to late adverse events. For instance, in October 2025, according to the World Health Organization, a US-based specialized health agency, the population of individuals aged 80 and above is projected to grow threefold by 2050, reaching an estimated 426 million. Therefore, the growing geriatric population is driving the growth of the bioabsorbable stents industry.

Key Players In The Global Bioabsorbable Stents Market

Major companies operating in the bioabsorbable stents market are Abbott Laboratories, REVA Medical Inc., Elixir Medical Corporation, Biotronik SE & Co. KG, Amaranth Medical Inc., Tepha Inc., S3V Vascular Technologies, Arterius Limited, MicroPort Scientific Corporation, Meril Life Sciences Pvt. Ltd., Stentys SA, OrbusNeich, Arterial Remodeling Technologies, Cardionovum GmbH, Envision Scientific Pvt. Ltd., Eurocor GmbH, Hexacath, Lifetech Scientific (Shenzhen) Co. Ltd., Manli Cardiology Limited, Sahajanand Medical Technologies Pvt. Ltd.

Global Bioabsorbable Stents Market Trends and Insights

Major companies operating in the bioabsorbable stents market are focusing on innovating new technologies, such as the Latest Generation of Bioresorbable Cardiac Stent, to increase their profitability in the market. The latest generation of bioresorbable cardiac stents refers to advanced medical devices designed for use in coronary artery disease treatment, which are made from biodegradable materials that dissolve over time after performing their function of keeping the artery open. For instance, in July 2024, MicroPort Scientific Corporation, a China-based medical device manufacturer, recently received market approval for the world's first next-generation fully bioresorbable cardiac stent from China's National Medical Products Administration (NMPA). Developed by MicroPort Scientific Corporation, Firesorb is designed to completely dissolve within three years, significantly reducing long-term complications such as thrombosis. Clinical trials involving 1,468 patients have shown impressive results, including a low thrombosis rate of 0.32% and a 4-year target lesion failure rate of just 4.3%. Leading medical experts have praised its innovative thin strut design and superior endothelial coverage compared to previous stent generations.

What Defines the Bioabsorbable Stents Market?

The bioabsorbable stents market consists of sales of polymer-based bioabsorbable stents and metal-based bioabsorbable stents. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Bioabsorbable Stents Market Report 2026?

The bioabsorbable stents market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the bioabsorbable stents industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.